Sheffield invests in warehouse and distribution; falling ruble pressures Indian companies;

> Sheffield Pharmaceuticals of New London, CT will invest $3.7 million in converting a building to a warehouse and distribution center there. Story

> The falling Russian currency poses a risk to the profitability of Indian pharma companies such as Dr. Reddy's, Glenmark and Ranbaxy. Story

> Norwich Pharma Services says it will focus on customers with commercial phase programs. Report

> India says it will release a list next month of what drugs will be added to those requiring price caps. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.